- Do you, or did you, own shares of Aerie Pharmaceuticals, Inc. (NASDAQ GM: AERI)?
- Did you purchase your shares between August 6, 2014 and April 23, 2015, inclusive?
- Did you lose money in your investment in Aerie Pharmaceuticals, Inc.?
Please contact Rigrodsky & Long, P.A. (“R & L”) to schedule a free consultation. You may call us or fill out our contact form so that we can call at your convenience. Your consultation will not create any obligation to use our services at any time.
R & L is investigating claims brought in a securities fraud class action complaint against Aerie Pharmaceuticals, Inc. ("Aerie") concerning whether Aerie and certain of the Company’s directors and/or officers made materially false and misleading statements and failed to disclose materially adverse facts during the period August 6, 2014 and April 23, 2015 (the “Class Period”), concerning the Company’s business, operations and prospects. These misrepresentations and omissions artificially inflated the price of the Company's stock throughout the Class Period.